Gujarat Kidney And Super Speciality Limited Share Price & Analysis
₹129.86▲ +2.23%Updated 21 Jul 2026, 05:01 pm IST
LTP
₹129.86
+2.23%
Open
₹—
High
₹132.33
Low
₹126.75
Close
₹129.86
52W High
₹148
52W Low
₹98.2
Volume
204K
Lot Size
1
Sector
Healthcare
Market Cap
₹1K Cr
Face Value
₹2
Small Cap
Price Chart
Fundamentals
P/E
65.3
Sector P/E
54.4
P/B
4.06
EPS
₹1.97
ROE
11.1%
ROCE
14.5%
D/E Ratio
0.11
Div Yield
0%
Book Value
₹32
+
Strengths
- ✓Low debt relative to equity (D/E 0.1x)
Peer Comparison
| Company | CMP | Mkt Cap | P/E | P/B | ROE % | ROCE % | D/E |
|---|---|---|---|---|---|---|---|
| SUNPHARMA Sun Pharmaceutical Industries Limited | ₹1,944 | ₹4.6L Cr | 37.3 | 5.59 | 16 | 20.5 | 0.07 |
| DIVISLAB Divi's Laboratories Limited | ₹7,388 | ₹1.9L Cr | 73.4 | 11.71 | 16.5 | 22 | 0.01 |
| TORNTPHARM Torrent Pharmaceuticals Limited | ₹5,040 | ₹1.6L Cr | 73.6 | 20.32 | 27.4 | 15.2 | 0.33 |
| APOLLOHOSP Apollo Hospitals Enterprise Limited | ₹8,939 | ₹1.3L Cr | 64.9 | 13.56 | 22.1 | 17.9 | 0.88 |
| CIPLA Cipla Limited | ₹1,416 | ₹1.1L Cr | 30.1 | 3.32 | 11.6 | 15.5 | 0.01 |
| ZYDUSLIFE Zydus Lifesciences Limited | ₹1,123 | ₹1.1L Cr | 21 | 4.17 | 21.2 | 21.1 | 0.38 |
| LUPIN Lupin Limited | ₹2,405 | ₹1.1L Cr | 19.6 | 4.9 | 28.7 | 29.9 | 0.32 |
Showing 7 peers in the same sector · Sorted by market cap
Corporate Events
To consider and approve the audited financial results for the quarter and year ended March 31, 2026 and other matters
Results27 May 2026
Financials
Quarterly Results
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | ₹30.58 Cr ▲31.5% | ₹23.25 Cr ▲79.8% | ₹12.93 Cr ▼15.3% | ₹15.26 Cr ▲56.0% | ₹9.78 Cr ▼17.0% | ₹11.79 Cr ▲25.3% | ₹9.41 Cr |
| Op. Profit | ₹6.3 Cr ▼8.7% | ₹6.9 Cr ▲34.8% | ₹5.12 Cr ▼40.6% | ₹8.62 Cr ▲230.3% | ₹2.61 Cr ▼43.3% | ₹4.6 Cr ▼5.3% | ₹4.86 Cr |
| OPM | 20.6% ▼30.6% | 29.7% ▼25.1% | 39.6% ▼29.9% | 56.5% ▲111.7% | 26.7% ▼31.6% | 39.0% ▼24.5% | 51.6% |
| Net Profit | ₹4.82 Cr ▲30.3% | ₹3.7 Cr ▲28.5% | ₹2.88 Cr ▼46.7% | ₹5.4 Cr ▲303.0% | ₹1.34 Cr ▼47.0% | ₹2.53 Cr ▼14.5% | ₹2.96 Cr |
| EPS (₹) | 0.64 ▲73.0% | 0.37 ▼21.3% | 0.47 ▼44.7% | 0.85 ▲269.6% | 0.23 ▼98.5% | 15.53 ▼15.6% | 18.39 |
Values in ₹ Cr · Source: Screener.in
Annual Profit & Loss
| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Revenue | ₹82 Cr ▲105.0% | ₹40 Cr ▲700.0% | ₹5 Cr | ₹0 Cr |
| Expenses | ₹55 Cr ▲129.2% | ₹24 Cr ▲700.0% | ₹3 Cr | ₹0 Cr |
| Op. Profit | ₹27 Cr ▲58.8% | ₹17 Cr ▲750.0% | ₹2 Cr | ₹0 Cr |
| OPM | 33.0% ▼19.5% | 41.0% ▲0.0% | 41.0% | — |
| Other Income | ₹1 Cr | ₹0 Cr ▼100.0% | ₹1 Cr | ₹0 Cr |
| Interest | ₹2 Cr ▲100.0% | ₹1 Cr | ₹0 Cr | ₹0 Cr |
| Depreciation | ₹5 Cr ▲66.7% | ₹3 Cr | ₹0 Cr | ₹0 Cr |
| PBT | ₹21 Cr ▲61.5% | ₹13 Cr ▲550.0% | ₹2 Cr | ₹0 Cr |
| Tax % | 21.0% ▼19.2% | 26.0% ▲4.0% | 25.0% | 0.0% |
| Net Profit | ₹17 Cr ▲70.0% | ₹10 Cr ▲400.0% | ₹2 Cr | ₹0 Cr |
| EPS (₹) | 1.97 ▲18.7% | 1.66 ▼98.1% | 85.5 ▲17200.0% | -0.5 |
| Div Payout | 0.0% | 0.0% | 0.0% | 0.0% |
Values in ₹ Cr · Source: Screener.in
Balance Sheet
| Item | Mar 2026 | Sep 2025 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|
| Liabilities | |||||
| Equity Capital | ₹16 Cr ▲40.7% | ₹11.37 Cr ▲3.4% | ₹11 Cr ▲5400.0% | ₹0.2 Cr ▲0.0% | ₹0.2 Cr |
| Reserves | ₹237 Cr ▲970.9% | ₹22.13 Cr ▲47.5% | ₹15 Cr ▲36.4% | ₹11 Cr | ₹0 Cr |
| Borrowings | ₹29 Cr ▲48.5% | ₹19.53 Cr ▲144.1% | ₹8 Cr ▲33.3% | ₹6 Cr | ₹0 Cr |
| Other Liabilities | ₹16 Cr ▼29.4% | ₹22.65 Cr ▲7.9% | ₹21 Cr ▲425.0% | ₹4 Cr ▲0.0% | ₹4 Cr |
| Total Liabilities | ₹298 Cr ▲293.8% | ₹75.68 Cr ▲37.6% | ₹55 Cr ▲161.9% | ₹21 Cr ▲425.0% | ₹4 Cr |
| Assets | |||||
| Fixed Assets | ₹129 Cr ▲338.3% | ₹29.43 Cr ▼5.1% | ₹31 Cr ▲121.4% | ₹14 Cr | ₹0 Cr |
| CWIP | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Investments | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Other Assets | ₹169 Cr ▲265.4% | ₹46.25 Cr ▲92.7% | ₹24 Cr ▲242.9% | ₹7 Cr ▲75.0% | ₹4 Cr |
| Total Assets | ₹298 Cr ▲293.8% | ₹75.68 Cr ▲37.6% | ₹55 Cr ▲161.9% | ₹21 Cr ▲425.0% | ₹4 Cr |
Values in ₹ Cr · Source: Screener.in
Cash Flow Statement
| Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Operating CF | — | ₹14 Cr ▲1300.0% | ₹1 Cr | ₹0 Cr |
| Investing CF | — | ₹-18 Cr | ₹0 Cr | ₹0 Cr |
| Financing CF | — | ₹6 Cr | ₹0 Cr | ₹0 Cr |
| Net Cash Flow | — | ₹2 Cr ▲100.0% | ₹1 Cr | ₹0 Cr |
| Free Cash Flow | — | ₹-5 Cr ▼350.0% | ₹2 Cr | ₹0 Cr |
Values in ₹ Cr · Source: Screener.in
Key Ratios History
| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Debtor Days | 172d ▲24.6% | 138d ▼57.0% | 321d | — |
| Inventory Days | 82d | — | — | — |
| Days Payable | 339d | — | — | — |
| Cash Conv. Cycle | -84d ▼160.9% | 138d ▼57.0% | 321d | — |
| Working Capital Days | 91d ▲479.2% | -24d ▼124.0% | 100d | — |
| ROCE | 14.0% ▼73.1% | 52.0% ▲173.7% | 19.0% | — |
Source: Screener.in · Lower days = better efficiency
About Gujarat Kidney And Super Speciality Limited
Incorporated in 2019, Gujarat Kidney and Super Speciality Limited specializes in providing multispeciality healthcare services.[1]
Healthcare · Healthcare Services
Related Analysis
Frequently Asked Questions
What is Gujarat Kidney And Super Speciality Limited share price today?▾
Gujarat Kidney And Super Speciality Limited (GKSL) is currently trading at ₹129.86 on NSE, up 2.23% as of the last market session. Prices update daily after market close on MarketNetra.
Is Gujarat Kidney And Super Speciality Limited available in F&O (Futures & Options)?▾
Yes, Gujarat Kidney And Super Speciality Limited (GKSL) is part of the NSE F&O segment with a lot size of 1 shares. Options are available with monthly expiry contracts. You can track the full option chain and OI analysis on MarketNetra.
What is Gujarat Kidney And Super Speciality Limited 52-week high and low?▾
Gujarat Kidney And Super Speciality Limited's 52-week high is ₹148 and the 52-week low is ₹98.2. The current price of ₹129.86 is 12.3% below the 52W high.
What is Gujarat Kidney And Super Speciality Limited P/E ratio?▾
Gujarat Kidney And Super Speciality Limited's current P/E ratio is 65.3. This indicates the market is paying ₹65.3 for every ₹1 of earnings. Compare this to the sector average to assess relative valuation.
How to trade Gujarat Kidney And Super Speciality Limited options?▾
Gujarat Kidney And Super Speciality Limited options are traded on NSE with monthly expiry contracts (lot size: 1 shares). To trade GKSL options: select your expiry on the option chain page, identify key OI strikes, check the PCR and buildup type on OI analysis, and review FII/DII flows for institutional sentiment before taking a position.